Cite
APA Citation
Constantine, G. D., Simon, J. A., Kaunitz, A. M., Pickar, J. H., Revicki, D. A., Graham, S., Bernick, B., & Mirkin, S. (2020). tX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial. Menopause, 27(11), . http://access.bl.uk/ark:/81055/vdc_100152022320.0x00001b